Back to top
more

Amphastar Pharmaceuticals (AMPH)

(Delayed Data from NSDQ)

$50.53 USD

50.53
262,685

-0.25 (-0.49%)

Updated Oct 31, 2024 04:00 PM ET

After-Market: $50.57 +0.04 (0.08%) 7:34 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 39% (98 out of 251)

Industry: Medical - Generic Drugs

Better trading starts here.

Zacks News

Wall Street Analysts Think Amphastar (AMPH) Is a Good Investment: Is It?

According to the average brokerage recommendation (ABR), one should invest in Amphastar (AMPH). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

The Zacks Analyst Blog Highlights Amphastar Pharmaceuticals, Journey Medical, Centessa Pharmaceuticals and Aquestive Therapeutics

Amphastar Pharmaceuticals, Journey Medical, Centessa Pharmaceuticals and Aquestive Therapeutics are part of the Zacks top Analyst Blog.

Zacks.com featured highlights include Amphastar Pharmaceuticals, Shift4 Payments, Beacon Roofing Supply, Hooker Furnishings and Hilltop Holdings

Amphastar Pharmaceuticals, Shift4 Payments, Beacon Roofing Supply, Hooker Furnishings and Hilltop Holdings are part of the Zacks Screen of the Week article.

Tenet Healthcare (THC) Gains 60% in a Year: More Room to Run?

Diversified treatment network, solid patient volumes in the Hospital segment and robust cash flows continue to drive Tenet Healthcare (THC).

Ahan Chakraborty headshot

What Awaits These 4 Drug Stocks That More Than Doubled in 2023?

Here are four drug, biotech stocks, AMPH, DERM, CNTA & AQST, which have more than doubled in 2023 with room for further growth in 2024.

Nilanjan Choudhury headshot

5 Good Opportunities on Relative Price Strength Strategy

AMPH, FOUR, BECN, HOFT and HTH are five stocks with explosive relative price strength.

3 Reasons Why Amphastar (AMPH) Is a Great Growth Stock

Amphastar (AMPH) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Centene (CNC) Ties Up to Aid Its Marketplace Members in Chicago

Centene's (CNC) product - Ambetter of Illinois - along with RUSH aim to provide improved access to quality healthcare services for CNC's members in Chicago, and thereby grow its Marketplace business.

Sanghamitra Saha headshot

What's in Store for Nasdaq in 2024? 5 Top Picks

After a strong 2023, we expect the Nasdaq to log gains in 2024. Top-ranked Nasdaq stocks GigaCloud Technology Inc (GCT), Carrols Restaurant Group (TAST), Limbach (LMB), Amphastar Pharmaceuticals (AMPH) and Insight Enterprises Inc (NSIT) could emerge as winning picks.

Vaishali Doshi headshot

Snap These 4 Top-Performing Liquid Stocks for Strong Returns

Here are four top-ranked liquid stocks, Puma Biotechnology (PBYI), Amphastar Pharmaceuticals (AMPH), DropBox (DBX) and GigaCloud Technology Inc. (GCT), which investors can add to their portfolio for solid gains.

3 Reasons Why Growth Investors Shouldn't Overlook Amphastar (AMPH)

Amphastar (AMPH) could produce exceptional returns because of its solid growth attributes.

Is Atossa Genetics (ATOS) Outperforming Other Medical Stocks This Year?

Here is how Atossa Genetics Inc. (ATOS) and Amphastar Pharmaceuticals (AMPH) have performed compared to their sector so far this year.

Zacks.com featured highlights Abercrombie & Fitch, Amphastar and NetEase

Abercrombie & Fitch, Amphastar and NetEase have been highlighted in this Screen of The Week article.

Are You Looking for a Top Momentum Pick? Why Amphastar Pharmaceuticals (AMPH) is a Great Choice

Does Amphastar Pharmaceuticals (AMPH) have what it takes to be a top stock pick for momentum investors? Let's find out.

Why You Should Retain UnitedHealth Group (UNH) Stock Now

Growing membership, expanding government business, strategic acquisitions, improving operating margin and solid growth outlook poise UnitedHealth Group (UNH) well for growth.

Tirthankar Chakraborty headshot

3 Best Momentum Stocks to Buy Using the Driehaus Strategy

Stocks like Abercrombie & Fitch (ANF), Amphastar Pharmaceuticals (AMPH) and NetEase (NTES) have been selected as the momentum picks for the day using the Driehaus strategy.

Centene (CNC) Wins Contract From Arizona's Medicaid Agency

Centene's (CNC) Arizona subsidiary has been chosen by the AHCCCS to improve health outcomes for the state's ALTCS-E/PD members and further solidify statewide presence.

Vaishali Doshi headshot

4 Top-Performing Liquid Stock Picks for Robust Returns

Here are four top-ranked liquid stocks, Puma Biotechnology (PBYI), Amphastar Pharmaceuticals (AMPH), DropBox (DBX), and Vimeo (VMEO), which investors can add to their portfolio for solid gains.

Amphastar (AMPH) Is Considered a Good Investment by Brokers: Is That True?

According to the average brokerage recommendation (ABR), one should invest in Amphastar (AMPH). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Here's Why Investors Should Retain Molina Healthcare (MOH) Now

Molina Healthcare (MOH) is well-poised for improvement on the back of membership growth in the Medicaid and Medicare businesses. Acquisitions and a solid cash balance act as added tailwinds.

Here's Why You Should Invest in Centene (CNC) Stock Now

Robust growth outlook, contract wins, accretive acquisitions and streamlining of businesses poise Centene (CNC) well for growth.

3 Reasons Why Growth Investors Shouldn't Overlook Amphastar (AMPH)

Amphastar (AMPH) possesses solid growth attributes, which could help it handily outperform the market.

Are Medical Stocks Lagging Cencora, Inc. (COR) This Year?

Here is how Cencora (COR) and Amphastar Pharmaceuticals (AMPH) have performed compared to their sector so far this year.

Wall Street Analysts See Amphastar (AMPH) as a Buy: Should You Invest?

According to the average brokerage recommendation (ABR), one should invest in Amphastar (AMPH). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Amphastar Pharmaceuticals (AMPH) Rises Yet Lags Behind Market: Some Facts Worth Knowing

In the most recent trading session, Amphastar Pharmaceuticals (AMPH) closed at $45.27, indicating a +0.2% shift from the previous trading day.